CD55 抗体
Our Local Distributor
北京 101111
Quick Overview for CD55 抗体 (ABIN7865618)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- anti-CD55 mouse monoclonal, 143-30, purified
-
纯化方法
- affinity chromatography
-
免疫原
- stimulated human leucocytes
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 100 μg/mL
-
缓冲液
- PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- store at 2 - 8 °C
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- CD55
-
背景
- 143-30 Reacts with CD55 or DAF (Decay Accelerating Factor). All leucocytes as well as human erythrocytes, fibroblasts, platelets, endothelial cells and neuroectodermal cells are positive for DAF, a glycosylphosphatidylinositol anchored (GPI-anchored) member of the membrane bound complement regulatory proteins that inhibit autologous complement cascade activation. CD55 also serves as receptor for CD97 and for echovirus and coxsackie B virus. DAF is deficient in both granulocytes and monocytes in patients with paroxysmal nocturnal haemoglobinuria. 143-30 Has been clustered in Vienna at the IVth International Workshop on human leucocyte differentiation antigens. Positive control: Jurkat, HUT-78, K562, YT, U937, MG63, and human lymphocytes, human lymph nodes and tonsils.
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-